Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 223

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Phenotypic Polarization of Activated Astrocytes: The Critical Role of Lipocalin-2 in the Classical Inflammatory Activation of Astrocytes

Jang, Eunha, Kim, Jong-Heon, Lee, Shinrye, Kim, Jae-Hong, Seo, Jung-Wan, Jin, Myungwon, Lee, Maan-Gee, Jang, Il-Sung, Lee, Won-Ha, Suk, Kyoungho · 2013 · The Journal of Immunology

Abstract

Astrocytes provide structural and functional support for neurons, as well as display neurotoxic or neuroprotective phenotypes depending upon the presence of an immune or inflammatory microenvironment. This study was undertaken to characterize multiple phenotypes of activated astrocytes and to investigate the regulatory mechanisms involved. We report that activated astrocytes in culture exhibit two functional phenotypes with respect to pro- or anti-inflammatory gene expression, glial fibrillary acidic protein expression, and neurotoxic or neuroprotective activities. The two distinct functional phenotypes of astrocytes were also demonstrated in a mouse neuroinflammation model, which showed pro- or anti-inflammatory gene expression in astrocytes following challenge with classical or alternative activation stimuli; similar results were obtained in the absence of microglia. Subsequent studies involving recombinant lipocalin-2 (LCN2) protein treatment or Lcn2-deficient mice indicated that the pro- or anti-inflammatory functionally polarized phenotypes of astrocytes and their intracellular signaling pathway were critically regulated by LCN2 under in vitro and in vivo conditions. Astrocyte-derived LCN2 promoted classical proinflammatory activation of astrocytes but inhibited IL-4–STAT6 signaling, a canonical pathway involved in alternative anti-inflammatory activation. Our results suggest that the secreted protein LCN2 is an autocrine modulator of the functional polarization of astrocytes in the presence of immune or inflammatory stimuli and that LCN2 could be targeted therapeutically to dampen proinflammatory astrocytic activation and related pathologies in the CNS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1301637

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Markiewicz, 2006, The role of astrocytes in the physiology and pathology of the central nervous system, Acta Neurobiol. Exp. (Warsz.), 66, 343, 10.55782/ane-2006-1623 · DOI
  2. Allan, 2003, Inflammation in central nervous system injury, Philos. Trans. R. Soc. Lond. B Biol. Sci., 358, 1669, 10.1098/rstb.2003.1358 · DOI · Paper page
  3. John, 2003, Cytokines: powerful regulators of glial cell activation, Neuroscientist, 9, 10, 10.1177/1073858402239587 · DOI · Paper page
  4. Kim, 2005, Microglia in health and disease, J. Neurosci. Res., 81, 302, 10.1002/jnr.20562 · DOI · Paper page
  5. Xu, 2012, Class A scavenger receptor promotes cerebral ischemic injury by pivoting microglia/macrophage polarization, Neuroscience, 218, 35, 10.1016/j.neuroscience.2012.05.036 · DOI
  6. David, 2011, Repertoire of microglial and macrophage responses after spinal cord injury, Nat. Rev. Neurosci., 12, 388, 10.1038/nrn3053 · DOI · Paper page
  7. Hu, 2012, Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia, Stroke, 43, 3063, 10.1161/STROKEAHA.112.659656 · DOI · Paper page
  8. Liu, 1995, Identification of a new acute phase protein, J. Biol. Chem., 270, 22565, 10.1074/jbc.270.38.22565 · DOI · Paper page
  9. Devireddy, 2005, A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake, Cell, 123, 1293, 10.1016/j.cell.2005.10.027 · DOI · Paper page
  10. Tong, 2005, Neutrophil gelatinase-associated lipocalin as a survival factor, Biochem. J., 391, 441, 10.1042/BJ20051020 · DOI · Paper page
  11. Flo, 2004, Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron, Nature, 432, 917, 10.1038/nature03104 · DOI · Paper page
  12. Wilkinson, 2001, Multiple roles of EPH receptors and ephrins in neural development, Nat. Rev. Neurosci., 2, 155, 10.1038/35058515 · DOI · Paper page
  13. Hamzic, 2013, Immune-induced expression of lipocalin-2 in brain endothelial cells: relationship with interleukin-6, cyclooxygenase-2 and the febrile response, J. Neuroendocrinol., 25, 271, 10.1111/jne.12000 · DOI
  14. Yan, 2007, The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance, Diabetes, 56, 2533, 10.2337/db07-0007 · DOI · Paper page
  15. Lee, 2007, A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia, J. Immunol., 179, 3231, 10.4049/jimmunol.179.5.3231 · DOI · Paper page
  16. Naudé, 2012, Lipocalin 2: novel component of proinflammatory signaling in Alzheimer’s disease, FASEB J., 26, 2811, 10.1096/fj.11-202457 · DOI · Paper page
  17. Ip, 2011, Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration, J. Neuroinflammation, 8, 124, 10.1186/1742-2094-8-124 · DOI
  18. Lee, 2009, Lipocalin-2 is an autocrine mediator of reactive astrocytosis, J. Neurosci., 29, 234, 10.1523/JNEUROSCI.5273-08.2009 · DOI · Paper page
  19. Berard, 2012, Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis, Glia, 60, 1145, 10.1002/glia.22342 · DOI
  20. Rathore, 2011, Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury, J. Neurosci., 31, 13412, 10.1523/JNEUROSCI.0116-11.2011 · DOI
  21. Dong, 2013, Role of iron in brain lipocalin 2 upregulation after intracerebral hemorrhage in rats, Brain Res., 1505, 86, 10.1016/j.brainres.2013.02.008 · DOI
  22. Marques, 2012, Lipocalin 2 is present in the EAE brain and is modulated by natalizumab, Front Cell Neurosci, 6, 33, 10.3389/fncel.2012.00033 · DOI
  23. Choi, 2011, Increased plasma levels of lipocalin 2 in mild cognitive impairment, J. Neurol. Sci., 305, 28, 10.1016/j.jns.2011.03.023 · DOI
  24. Chia, 2011, Expression and localization of the iron-siderophore binding protein lipocalin 2 in the normal rat brain and after kainate-induced excitotoxicity, Neurochem. Int., 59, 591, 10.1016/j.neuint.2011.04.007 · DOI
  25. McCarthy, 1980, Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue, J. Cell Biol., 85, 890, 10.1083/jcb.85.3.890 · DOI · Paper page
  26. Kerstetter, 2012, Isolation and culture of spinal cord astrocytes, Methods Mol. Biol., 814, 93, 10.1007/978-1-61779-452-0_7 · DOI
  27. Ock, 2010, Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation, Br. J. Pharmacol., 159, 1646, 10.1111/j.1476-5381.2010.00659.x · DOI
  28. Lee, 2012, Regulation by lipocalin-2 of neuronal cell death, migration, and morphology, J. Neurosci. Res., 90, 540, 10.1002/jnr.22779 · DOI
  29. Lee, 2011, Lipocalin-2 is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration, J. Biol. Chem., 286, 43855, 10.1074/jbc.M111.299248 · DOI · Paper page
  30. Cheeran, 2003, CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10, J. Virol., 77, 4502, 10.1128/JVI.77.8.4502-4515.2003 · DOI
  31. Park, 2002, Hypoxia induces nitric oxide production in mouse microglia via p38 mitogen-activated protein kinase pathway, Brain Res. Mol. Brain Res., 107, 9, 10.1016/S0169-328X(02)00421-7 · DOI
  32. Van Rooijen, 1994, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, J. Immunol. Methods, 174, 83, 10.1016/0022-1759(94)90012-4 · DOI · Paper page
  33. Steel, 2010, Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNS, J. Neuroimmunol., 226, 81, 10.1016/j.jneuroim.2010.05.034 · DOI
  34. Lee, 2002, Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase, J. Neurosci., 22, 7931, 10.1523/JNEUROSCI.22-18-07931.2002 · DOI · Paper page
  35. Lee, 2012, Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects, J. Biol. Chem., 287, 9414, 10.1074/jbc.M111.330662 · DOI
  36. Zhou, 2006, Activation of Group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake, J. Neurosci. Res., 84, 268, 10.1002/jnr.20897 · DOI
  37. McNaught, 2000, Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation, Biochem. Pharmacol., 60, 979, 10.1016/S0006-2952(00)00415-9 · DOI
  38. Bluthé, 2002, Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats, Neuropsychopharmacology, 26, 86, 10.1016/S0893-133X(01)00305-0 · DOI
  39. Hvidberg, 2005, The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake, FEBS Lett., 579, 773, 10.1016/j.febslet.2004.12.031 · DOI · Paper page
  40. O’Shea, 2004, A new modality for immunosuppression: targeting the JAK/STAT pathway, Nat. Rev. Drug Discov., 3, 555, 10.1038/nrd1441 · DOI · Paper page
  41. Ridet, 1997, Reactive astrocytes: cellular and molecular cues to biological function, Trends Neurosci., 20, 570, 10.1016/S0166-2236(97)01139-9 · DOI · Paper page
  42. Matyash, 2010, Heterogeneity in astrocyte morphology and physiology, Brain Res. Brain Res. Rev., 63, 2, 10.1016/j.brainresrev.2009.12.001 · DOI · Paper page
  43. Chaboub, 2012, Developmental origins of astrocyte heterogeneity: the final frontier of CNS development, Dev. Neurosci., 34, 379, 10.1159/000343723 · DOI
  44. McKhann, 1997, Heterogeneity of astrocyte resting membrane potentials and intercellular coupling revealed by whole-cell and gramicidin-perforated patch recordings from cultured neocortical and hippocampal slice astrocytes, J. Neurosci., 17, 6850, 10.1523/JNEUROSCI.17-18-06850.1997 · DOI
  45. Olsen, 2007, Differential distribution of Kir4.1 in spinal cord astrocytes suggests regional differences in K+ homeostasis, J. Neurophysiol., 98, 786, 10.1152/jn.00340.2007 · DOI
  46. Israel, 2003, GABAA receptor-expressing astrocytes in the supraoptic nucleus lack glutamate uptake and receptor currents, Glia, 44, 102, 10.1002/glia.10272 · DOI
  47. Wallraff, 2004, Distinct types of astroglial cells in the hippocampus differ in gap junction coupling, Glia, 48, 36, 10.1002/glia.20040 · DOI · Paper page
  48. Regan, 2007, Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS, J. Neurosci., 27, 6607, 10.1523/JNEUROSCI.0790-07.2007 · DOI · Paper page
  49. Pivneva, 2008, Store-operated Ca2+ entry in astrocytes: different spatial arrangement of endoplasmic reticulum explains functional diversity in vitro and in situ, Cell Calcium, 43, 591, 10.1016/j.ceca.2007.10.004 · DOI
  50. Emsley, 2006, Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS, Neuron Glia Biol., 2, 175, 10.1017/S1740925X06000202 · DOI · Paper page
  51. Bachoo, 2004, Molecular diversity of astrocytes with implications for neurological disorders, Proc. Natl. Acad. Sci. USA, 101, 8384, 10.1073/pnas.0402140101 · DOI · Paper page
  52. Brahmachari, 2006, Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide, J. Neurosci., 26, 4930, 10.1523/JNEUROSCI.5480-05.2006 · DOI · Paper page
  53. Mizuno, 2005, Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes, Brain Res., 1066, 78, 10.1016/j.brainres.2005.10.050 · DOI
  54. Zeng, 2012, Modified Wu-Zi-Yan-Zong prescription, a traditional Chinese polyherbal formula, suppresses lipopolysaccharide-induced neuroinflammatory processes in rat astrocytes via NF-κB and JNK/p38 MAPK signaling pathways, Phytomedicine, 19, 122, 10.1016/j.phymed.2011.08.003 · DOI
  55. von Boyen, 2004, Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia, Gut, 53, 222, 10.1136/gut.2003.012625 · DOI · Paper page
  56. Bélanger, 2011, Differential effects of pro- and anti-inflammatory cytokines alone or in combinations on the metabolic profile of astrocytes, J. Neurochem., 116, 564, 10.1111/j.1471-4159.2010.07135.x · DOI
  57. Koeberle, 2004, Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells, Neuroscience, 125, 903, 10.1016/S0306-4522(03)00398-1 · DOI
  58. Brodie, 1998, Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion, J. Neuroimmunol., 81, 20, 10.1016/S0165-5728(97)00154-9 · DOI
  59. Ahn, 2012, Immunohistochemical study of arginase-1 in the spinal cords of rats with clip compression injury, Brain Res., 1445, 11, 10.1016/j.brainres.2012.01.045 · DOI
  60. Garg, 2009, IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes, J. Neurochem., 108, 1155, 10.1111/j.1471-4159.2009.05872.x · DOI
  61. Park, 2012, Astrocytes, but not microglia, rapidly sense H2O2 via STAT6 phosphorylation, resulting in cyclooxygenase-2 expression and prostaglandin release, J. Immunol., 188, 5132, 10.4049/jimmunol.1101600 · DOI
  62. Tarassishin, 2011, Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*, Glia, 59, 1911, 10.1002/glia.21233 · DOI
  63. Li, 2011, Lipocalin 2 regulation and its complex role in inflammation and cancer, Cytokine, 56, 435, 10.1016/j.cyto.2011.07.021 · DOI

Cited by

See all 223

Metadata

Authors
Jang, E., Kim, J.-H., Lee, S., Kim, J.-H., Seo, J.-W., Jin, M., Lee, M.-G., Jang, I.-S., Lee, W.-H., & Suk, K.
Venue
The Journal of Immunology
Published
2013-11
Volume
191
Issue
10
Pages
5204-5219
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1957752652
Cited by
223
References
17
FWCI
4.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.